Prospect of Immunotherapy for Glioblastoma: Tumor Vaccine, Immune Checkpoint Inhibitors and Combination Therapy

To date, clinical trials of various vaccine therapies using autologous tumor antigens or tumor-associated/specific antigen peptide with adjuvants have been performed to treat patients with high-grade gliomas (HGG). Furthermore, immune checkpoint pathway-targeted therapies including anti-programmed c...

Descripción completa

Detalles Bibliográficos
Autores principales: ISHIKAWA, Eiichi, YAMAMOTO, Tetsuya, MATSUMURA, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Neurosurgical Society 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566705/
https://www.ncbi.nlm.nih.gov/pubmed/28539528
http://dx.doi.org/10.2176/nmc.ra.2016-0334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566705/
https://www.ncbi.nlm.nih.gov/pubmed/28539528
http://dx.doi.org/10.2176/nmc.ra.2016-0334

Ejemplares similares